GSP Crop Science Ltd has launched its IPO, with a price band of ₹304 to ₹320 per share. The IPO is currently underwhelming in terms of subscription rates.
GSP Crop Science is a research-driven agrochemical company specializing in the development and manufacturing of insecticides, herbicides, fungicides, and plant growth regulators. The company has recently launched its Initial Public Offering (IPO) with a price band set between ₹304 to ₹320 per share, aiming to raise a total of ₹400 crore. This amount includes ₹160 crore reserved for Offer for Sale (OFS) and ₹240 crore to be raised through fresh shares.
The IPO, which opened on March 16, 2026, is set to remain open until March 18, 2026. As of 2:54 PM on Day 1, the overall subscription rate stood at 0.41 times, with the retail portion subscribed at 0.07 times and the Non-Institutional Investors (NII) segment at 0.19 times. In contrast, the Qualified Institutional Buyers (QIB) segment has shown more interest, being subscribed 1.19 times.
Each lot of the IPO comprises 46 shares, making it accessible for various types of investors. However, the current Grey Market Premium (GMP) is reported to be ₹0, indicating a lack of enthusiasm in the grey market for these shares.
The most likely date for share allocation is March 19, 2026, with the IPO expected to list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) on March 23, 2026. Observers are keenly watching how the subscription rates will evolve in the coming days, especially given the low initial interest from retail and NII investors.
Initial reactions from market analysts suggest that the lack of interest in the retail and NII segments could pose challenges for GSP Crop Science as it seeks to establish a foothold in the public market. The company’s performance in the coming days will be critical in determining investor sentiment.
As the IPO progresses, it remains to be seen whether GSP Crop Science can attract more subscriptions before the closing date. The company’s future in the stock market will depend significantly on its ability to engage potential investors effectively.
Details remain unconfirmed regarding any strategic initiatives the company may undertake to boost interest in its IPO. Stakeholders are advised to stay updated on further developments as the situation unfolds.
